Literature DB >> 12097203

Fractures in patients with hyperthyroidism and hypothyroidism: a nationwide follow-up study in 16,249 patients.

Peter Vestergaard1, Leif Mosekilde.   

Abstract

AIM: To study fracture risk in patients with hyperthyroidism and hypothyroidism. SUBJECTS AND METHODS: All patients with hyperthyroidism or autoimmune hypothyroidism diagnosed for the first time between 1983 and 1996 in Denmark were identified through the National Patient Discharge Register. Each patient was compared with three age- and gender-matched controls randomly selected from the general population. Fracture occurrence before and after diagnosis was compared between patients and controls.
RESULTS: 11,776 patients with hyperthyroidism (6301 patients with diffuse toxic goiter, mean age, 52.1 +/- 18.6 years, and 5475 with nodular toxic goiter, mean age, 60.4 +/- 15.9 years), and 4473 patients with hypothyroidism (mean age, 66.1 +/- 17.3) were identified. In patients with hyperthyroidism, fracture risk was only significantly increased around the time of diagnosis (incidence rate ratio [IRR] between 1.26 and 2.29), but decreased to normal levels after diagnosis. Surgical treatment of hyperthyroidism was associated with a decreased fracture risk after diagnosis (RR = 0.66, 95% confidence interval [CI]: 0.55-0.78). In hypothyroidism, fracture risk was significantly increased both before and after diagnosis with a peak around the time of diagnosis (IRR between 2.17 and 2.35).
CONCLUSIONS: Fracture risk is increased in hyperthyroidism and hypothyroidism. Thyroid surgery seems associated with a decreased fracture risk in hyperthyroid patients.

Entities:  

Mesh:

Year:  2002        PMID: 12097203     DOI: 10.1089/105072502760043503

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  71 in total

1.  Optimal bone strength and mineralization requires the type 2 iodothyronine deiodinase in osteoblasts.

Authors:  J H Duncan Bassett; Alan Boyde; Peter G T Howell; Richard H Bassett; Thomas M Galliford; Marta Archanco; Holly Evans; Michelle A Lawson; Peter Croucher; Donald L St Germain; Valerie Anne Galton; Graham R Williams
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-05       Impact factor: 11.205

Review 2.  Role and Mechanisms of Actions of Thyroid Hormone on the Skeletal Development.

Authors:  Ha-Young Kim; Subburaman Mohan
Journal:  Bone Res       Date:  2013-06-28       Impact factor: 13.567

3.  Bone: Does TSH concentration influence skeletal health?

Authors:  Douglas C Bauer
Journal:  Nat Rev Endocrinol       Date:  2009-05       Impact factor: 43.330

Review 4.  The multiple faces of autoimmune-mediated bone loss.

Authors:  Georg Schett; Jean-Pierre David
Journal:  Nat Rev Endocrinol       Date:  2010-11-02       Impact factor: 43.330

Review 5.  Screening for celiac disease in the general population and in high-risk groups.

Authors:  Jonas F Ludvigsson; Timothy R Card; Katri Kaukinen; Julio Bai; Fabiana Zingone; David S Sanders; Joseph A Murray
Journal:  United European Gastroenterol J       Date:  2015-04       Impact factor: 4.623

6.  Advanced bone formation in mice with a dominant-negative mutation in the thyroid hormone receptor β gene due to activation of Wnt/β-catenin protein signaling.

Authors:  Patrick J O'Shea; Dong Wook Kim; John G Logan; Sean Davis; Robert L Walker; Paul S Meltzer; Sheue-yann Cheng; Graham R Williams
Journal:  J Biol Chem       Date:  2012-03-22       Impact factor: 5.157

Review 7.  Management of endocrine disease: Secondary osteoporosis: pathophysiology and management.

Authors:  Faryal Mirza; Ernesto Canalis
Journal:  Eur J Endocrinol       Date:  2015-05-13       Impact factor: 6.664

8.  Association between calcaneus quantitative ultrasound (QUS) parameters and thyroid status in middle-aged and elderly Chinese men with euthyroidism: a population-based cross-sectional study.

Authors:  Yun Shi; Min Sun; Zhixiao Wang; Qi Fu; Mengdie Cao; Zhenxin Zhu; Chuchen Meng; Jia Mao; Yu Duan; Wei Tang; Xiaoping Huang; Jieli Lu; Yufang Bi; Guang Ning; Wei He; Tao Yang
Journal:  Endocrine       Date:  2014-01-24       Impact factor: 3.633

9.  Can bone loss be reversed by antithyroid drug therapy in premenopausal women with Graves' disease?

Authors:  Tina Z Belsing; Charlotte Tofteng; Bente L Langdahl; Peder Charles; Ulla Feldt-Rasmussen
Journal:  Nutr Metab (Lond)       Date:  2010-09-01       Impact factor: 4.169

10.  FRAX and the assessment of fracture probability in men and women from the UK.

Authors:  J A Kanis; O Johnell; A Oden; H Johansson; E McCloskey
Journal:  Osteoporos Int       Date:  2008-02-22       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.